News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,746 Results
Type
Article (63831)
Company Profile (117)
Press Release (595798)
Multimedia
Podcasts (63)
Webinars (13)
Section
Business (177071)
Career Advice (2831)
Deals (32866)
Drug Delivery (100)
Drug Development (77676)
Employer Resources (154)
FDA (15171)
Job Trends (14259)
News (310071)
Policy (29449)
Tag
Academia (2931)
Academic (2)
Accelerated approval (6)
Adcomms (23)
Allergies (92)
Alliances (44507)
ALS (95)
Alzheimer's disease (1336)
Antibody-drug conjugate (ADC) (121)
Approvals (15180)
Artificial intelligence (278)
Autoimmune disease (24)
Automation (15)
Bankruptcy (299)
Best Places to Work (11114)
BIOSECURE Act (16)
Biosimilars (104)
Biotechnology (86)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (287)
Cancer (2255)
Cardiovascular disease (171)
Career advice (2402)
Career pathing (33)
CAR-T (161)
Cell therapy (451)
Cervical cancer (21)
Clinical research (63120)
Collaboration (837)
Company closure (2)
Compensation (361)
Complete response letters (20)
COVID-19 (2627)
CRISPR (46)
C-suite (270)
Cystic fibrosis (102)
Data (2269)
Decentralized trials (2)
Denatured (27)
Depression (45)
Diabetes (257)
Diagnostics (6231)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (118)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (89)
Earnings (61615)
Editorial (41)
Employer branding (19)
Employer resources (135)
Events (97282)
Executive appointments (776)
FDA (16540)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (779)
Gene editing (118)
Generative AI (21)
Gene therapy (314)
GLP-1 (684)
Government (4544)
Grass and pollen (6)
Guidances (149)
Healthcare (18594)
Huntington's disease (19)
IgA nephropathy (26)
Immunology and inflammation (114)
Indications (28)
Infectious disease (2766)
Inflammatory bowel disease (149)
Inflation Reduction Act (8)
Influenza (56)
Intellectual property (98)
Interviews (540)
IPO (14980)
IRA (38)
Job creations (3534)
Job search strategy (2016)
Kidney cancer (10)
Labor market (35)
Layoffs (518)
Leadership (22)
Legal (6559)
Liver cancer (70)
Lung cancer (311)
Lymphoma (149)
Machine learning (9)
Management (53)
Manufacturing (306)
MASH (72)
Medical device (12894)
Medtech (12899)
Mergers & acquisitions (18480)
Metabolic disorders (658)
Multiple sclerosis (79)
NASH (13)
Neurodegenerative disease (89)
Neuropsychiatric disorders (26)
Neuroscience (1869)
NextGen: Class of 2025 (6523)
Non-profit (4520)
Now hiring (27)
Obesity (333)
Opinion (241)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (84)
Parkinson's disease (144)
Partnered (21)
Patents (242)
Patient recruitment (115)
Peanut (51)
People (60110)
Pharmaceutical (25)
Pharmacy benefit managers (16)
Phase I (19902)
Phase II (27835)
Phase III (20334)
Pipeline (1300)
Policy (137)
Postmarket research (2502)
Preclinical (8581)
Press Release (68)
Prostate cancer (108)
Psychedelics (28)
Radiopharmaceuticals (251)
Rare diseases (372)
Real estate (6115)
Recruiting (64)
Regulatory (20472)
Reports (35)
Research institute (2467)
Resumes & cover letters (421)
Rett syndrome (6)
RNA editing (3)
RSV (35)
Schizophrenia (69)
Series A (134)
Series B (90)
Service/supplier (11)
Sickle cell disease (53)
Special edition (12)
Spinal muscular atrophy (150)
Sponsored (31)
Startups (3441)
State (1)
Stomach cancer (10)
Supply chain (57)
Tariffs (37)
The Weekly (34)
Vaccines (690)
Venture capitalists (38)
Weight loss (207)
Women's health (32)
Worklife (19)
Date
Today (36)
Last 7 days (910)
Last 30 days (2814)
Last 365 days (30658)
2025 (11218)
2024 (32859)
2023 (37103)
2022 (47580)
2021 (52500)
2020 (51593)
2019 (45698)
2018 (34745)
2017 (31310)
2016 (30704)
2015 (36380)
2014 (29273)
2013 (25744)
2012 (26807)
2011 (27087)
2010 (25534)
Location
Africa (909)
Alabama (56)
Alaska (6)
Arizona (176)
Arkansas (14)
Asia (38982)
Australia (6953)
California (5888)
Canada (1937)
China (515)
Colorado (254)
Connecticut (265)
Delaware (152)
Europe (90291)
Florida (889)
Georgia (209)
Idaho (56)
Illinois (561)
India (25)
Indiana (294)
Iowa (10)
Japan (162)
Kansas (100)
Kentucky (24)
Louisiana (11)
Maine (61)
Maryland (870)
Massachusetts (4284)
Michigan (229)
Minnesota (351)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (61)
New Hampshire (61)
New Jersey (1701)
New Mexico (29)
New York (1707)
North Carolina (980)
North Dakota (9)
Northern California (2590)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1290)
Puerto Rico (13)
Rhode Island (31)
South America (1220)
South Carolina (19)
South Dakota (1)
Southern California (2223)
Tennessee (99)
Texas (890)
United States (22303)
Utah (181)
Virginia (148)
Washington D.C. (52)
Washington State (538)
West Virginia (3)
Wisconsin (63)
659,746 Results for "purdue university weldon school of biomedical engineering".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Trump Administration Pulls CDC Nominee Dave Weldon at Last Minute
As Marty Makary and Jay Bhattacharya sail through the Senate health committee vote, Weldon’s confirmation hearing is canceled. Guggenheim Partners heralded the last-minute move to revoke Dave Weldon’s nomination as “a positive sign for reigning in vaccine criticism.”
March 13, 2025
·
1 min read
·
Annalee Armstrong
Podcasts
Sarepta’s Elevidys Death, FDA’s Vaccine Move, Weldon Whiplash, PDUFAs in Cardio
Sarepta will update Elevidys’ label after a patient died following treatment; the FDA issues flu vaccine recommendations without advisor input; Trump CDC nominee Dave Weldon pulled at last minute; and FDA decisions expected for Alnylam’s Amvuttra in ATTR-CM and Milestone’s etripamil in tachycardia.
March 19, 2025
·
2 min read
·
Heather McKenzie
Government
Trump Picks Vaccine Critic Weldon to Lead CDC, Makary for FDA Head
Career conservative and former congressman Dave Weldon will, if confirmed, act as director of the Centers of Disease Control and Prevention, where his anti-vaccine views will mesh with those of selected Department of Health and Human Services head Robert F. Kennedy Jr.
November 25, 2024
·
2 min read
·
Tristan Manalac
Partnered
Making the Grade: Drexel’s Biomedical Sciences Programs Boost Careers at All Stages
At Drexel University’s Graduate School of Biomedical Sciences and Professional Studies, graduate students and active professionals can take interdisciplinary, career-oriented programs designed to help launch their careers and take them to the next level.
December 3, 2024
·
5 min read
·
BioSpace Insights
Bankruptcy
Purdue Files for Bankruptcy Anew to Support $7.4B+ Opioid Settlement
The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the Sackler family too much protection.
March 20, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
CorDx’s Aiiso Yufeng Li Family Gifts $21M to UC San Diego Jacobs School of Engineering to Further Chemical and Nano Engineering Research, Education, and Student Activities
CorDx announced a transformative $21M gift to the University of California San Diego’s Jacobs School of Engineering from CorDx founder Aiiso Yufeng Li, with support from members of the CorDx family – Li’s wife, Aiiso DongDong Li, Mac Chen, Haixia Yang, Monica Hu, and others at CorDx.
May 21, 2024
·
6 min read
Vaccines
CDC Vaccine Advisors to Meet in April as Trump Eyes New Agency Director
After withdrawing its nomination for Dave Weldon last week, the Trump administration is now reportedly considering Texas Republican Michael Burgess to head the Centers for Disease Control and Prevention.
March 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
April 11, 2025
·
7 min read
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
April 10, 2025
·
5 min read
Podcast
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC director nominee; Novo Nordisk joins the triple-G race; Alnylam wins approval for Amvuttra in ATTR-CM; and Cassava Sciences ends development of simufilam in Alzheimer’s.
March 26, 2025
·
1 min read
·
Heather McKenzie
1 of 65,975
Next
